Sign In
Buy TRCK
$0.643
-0.0072 (-1.11%)
At Close: Jul 31, 2026
RSST: Solid Futures ETF, Good Performance Track-Record, Potential Source Of Diversification
04:13am, Saturday, 22'nd Jun 2024
RSST provides exposure to U.S. large-cap equities and a managed futures strategy. The fund's strategy has been broadly effective in the past, with strong returns and moderate risk. I'm bullish, but th
SoundHound AI Acquires Ordering Platform Allset to Fast-Track Its Vision of a Voice Commerce Ecosystem
09:28am, Thursday, 20'th Jun 2024
SANTA CLARA, Calif., & LOS ANGELES--(BUSINESS WIRE)---- $SOUN #acquisition--SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice artificial intelligence, today announced the acquisition of key
Wall Street On Track To Resume Meteoric Climb, Nvidia Builds On Gains: Analyst Says 'Now Until Later In The Month Is
07:25am, Thursday, 20'th Jun 2024
U.S. stocks will likely carry over from where they left off as the market reopens after the Juneteenth holiday on Thursday. The major index futures were all uniformly higher, underpinned by the contin
Is Disney Animation Back on Track?
05:19am, Wednesday, 19'th Jun 2024
A huge opening weekend for Inside Out 2 is a great sign for Disney.
LL Flooring Mails Letter to Shareholders Highlighting Thomas Sullivan's Track Record of Value Destruction
08:00am, Tuesday, 18'th Jun 2024
RICHMOND, Va.--(BUSINESS WIRE)--LL Flooring Holdings, Inc. (“LL Flooring” or “Company”) (NYSE: LL) today mailed a letter to shareholders in connection with the Company's upcoming 2024 Annual M
Rail Vision Installed its AI-Driven Product with Loram, a Top US-Based Railway Track Maintenance Supplier
09:29am, Friday, 14'th Jun 2024
Ra'anana, Israel, June 14, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related ma
Contineum: LPA1R Antagonist Drug Advancement Against IPF With Proven Track Model
02:03pm, Thursday, 13'th Jun 2024
Contineum Therapeutics, Inc. PIPE-791 is being developed for the treatment of neuroinflammatory disorders like idiopathic pulmonary fibrosis and Progressive Multiple Sclerosis. The global idiopathic p
SAN FRANCISCO and SUZHOU, China, June 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercial
Ero Copper's Tucumã Project Awarded Operational License - Commissioning On Track for First Copper Production Early Q3 2024
07:00am, Wednesday, 12'th Jun 2024
(all amounts in US dollars, unless otherwise noted) VANCOUVER, British Columbia, June 12, 2024 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) is pleased to announce tha
Have $10,000? 3 Growth Stocks on Track to Double by 2028
06:36am, Wednesday, 12'th Jun 2024
Growth stocks have always captured investors' attention due to their potential for explosive returns. As we look ahead to 2028, several growth stocks will potentially double in value.
Tiziana Life Sciences seeks FDA Fast Track Designation for foralumab in MS treatment
10:05am, Tuesday, 11'th Jun 2024
Tiziana Life Sciences Ltd (NASDAQ:TLSA), said it is seeking Fast Track Designation approval from the US Food and Drug Administration (FDA) for its intranasal foralumab therapy to treat non-active, sec
Up 70% for the Year and On Track to Hit a New All-Time High, Is Ethereum a Buy?
05:38am, Thursday, 06'th Jun 2024
Investors are counting on the approval of new spot Ethereum ETFs to send the crypto soaring higher. The ETF investment thesis for Ethereum may be getting overhyped.
Colgate Women's Games Returns for 49th Season
10:00am, Wednesday, 05'th Jun 2024
NEW YORK--(BUSINESS WIRE)--Today on Global Running Day, Colgate-Palmolive Company announced that Colgate Women's Games, the nation's longest-running indoor Track & Field series for girls and women, wi
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
07:00am, Wednesday, 05'th Jun 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the U.S.
